Abstract. The ability of the chick embryo chorioallantoic membrane (CAM) to withstand invasion by tumor ceils can be intentionally compromised by altering its morphological integrity. Using a newly developed quantitative assay of invasion we showed that intact CAMs were completely resistant to invasion by tumor cells, wounded CAMs did not pose a barrier to penetration, and CAMs that were wounded and then allowed to reseal displayed partial susceptibility to invasion. The invasion of resealed CAMs required catalytically active plasminogen activator (PA) of the urokinase type (uPA); the invasive efficiency of tumor cells was reduced by 75% when tumor uPA activity or tumor uPA production was inhibited. The invasive ability of human tumor cells, which have surface uPA receptors but which do not produce the enzyme, could be augmented by saturating their receptors with exogenous uPA. The mere stimulation of either uPA or tissue plasminogen activator production, in absence of binding to cell receptors, did not result in an enhancement of invasiveness.
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These findings suggest that the increased invasive potential of tumor cells is correlated with cell surface-associated proteolytic activity stemming from the interaction between uPA and its surface receptor.
OCAL infiltration of normal tissue by tumor cells and their dissemination to distant sites involve migration through the stroma of connective tissue as well as the penetration of natural barriers, such as basement membranes. The invasiveness of tumor cells has been studied in a variety of experimental models (Albini et al., 1987; Foltz et al., 1982; Jones et al., 1981; Mignatti et al., 1986; Starkey et al., 1984; Terranova et al., 1986) , including the chorioallantoic membrane (CAM) ~ (Armstrong et al., 1982; Leighton, 1964; Ossowski and Reich, 1983; Poste et al., 1980; Poste and Flood, 1979; Scher et al., 1976) . It has been shown in a number of these models that tumor cells elaborate enzymes that can degrade components of the extracellular matrix (Dane et al., 1985; Jones et al., 1981; Mignatti et al., 1986; Nakajima et al., 1984; Salo et al., 1982; Sas et al., 1986; Sloane et al., 1986) . In most cases enhanced metastatic potential of cells was shown to be correlated with their greater ability to degrade matrix components (Dane et al., 1985; Jones et al., 1981; Liotta et al., 1980; Salo et al., 1982; Sloane et al., 1986; Terranova et al., 1986) but some lack of correlation has also been observed (Sas et al., 1986) . It is conceivable that the above discrepancies were due to an inability to mimic in vitro the highly specialized interactions that occur in vivo between tumor cells and the complex and heterogenous extracellular components.
1. Abbreviations used in this paper: CAM, chorioallantoic membrane; EGF, epidermal growth factor; HMW-uPA, high molecular weight urokinase-type plasminogen activator; PA, plasminogen activator; tPA, tissue-type plasminogen activator; uPA, urokinase-type plasminogen activator.
The CAM model, which combines the technical simplicity of an in vitro assay with the advantages of an in vivo environment, has been used in the past by a number of investigators to study the invasiveness of viraUy transformed cells or tumor cell lines, however, the role of preteolytic enzymes in invasion has not been studied in this model. The results of these studies have been conflicting probably because, with few exceptions (Armstrong et al., 1982) , the morphological integrity of CAMs used for inoculations was not carefully assessed. Indeed, histological assessment of CAMs in the present study revealed that the method "used for their preparation had a pronounced effect on their morphology. The susceptibility of these CAMs to tumor cell invasion was correlated with their structural integrity. This observation was used in preparation of CAMs that were completely, partially, or minimally resistant to tumor cell invasion.
The use of partially resistant CAMs permitted the examination of the role of plasminogen activator (PA) content, PA type (urokinase-type PA [uPA] vs. tissue-type PA [tPA]), and PA localization (soluble in the medium vs. surface receptor bound) in invasion of CAMs by tumor cells. Plasma membrane receptors for uPA have been recently identified on a number of cells , including tumor cells (Stoppelli et al., 1986) . uPA binds to these receptors via the amino-terminal portion of the molecule and remains catalytically active (Appella et al., 1987; Stoppelli et al., 1986; Vassalli et al., 1985) . In most uPA-producing cells the receptors are fully occupied by the endogenously produced enzyme (Stoppelli et al., 1986) but, as will be shown, in some cells the receptor is synthesized in the absence of uPA production.
Saturation of these receptors with exogenously added uPA, which remains active on the surface of the cells, allowed the testing of its role in enhancing tumor cell invasion. Also, since human receptors only bind human uPA (Appella et al., 1987; Huarte et al., 1987) we were able, by using human cells expressing very high levels of muse uPA, to determine whether overproduction of uPA, which because of its origin cannot bind to human uPA receptors, will equip the cells with an increased invasive potential.
Materials and Methods

Materials
COFAL-negative embryonated eggs were obtained from Spafas, Inc. (Norwich, CT); DME from Gibco Laboratories (Grand Island, NY); FBS from Hazleton Research Products Inc. (Lenexa, KS); '25IUdR (specific activity of 2,200 Ci/mmol) from New England Nuclear (Boston, MA); human urokinase standard from Leo Pharmaceuticals (Ballerup, Denmark), Breokinase (high molecular weight urokinase) from Green Cross Corp. (supplied by Breon Lab. Inc., NY), Abbokinase (low molecular weight urokinase) from Abbott Laboratories (North Chicago, IL); Triton X-100, coUagenase type 1A, and DMSO from Sigma Chemical Co. (St. Louis, MO); chromogenie substrate for plasmin (Spectrozyme PL) from American Diagnostica Inc. (New York, NY). Human plasminogen was purified from fresh human plasma as previously described (Deutsch and Mertz, 1970) ; bovine fibrinogen (Calbiochem-Behring Corp., La Jolla, CA) and rabbit anti-human uPA were prepared as described (Strickland and Beers, 1976; Ossowski and Reich, 1983) ; rabbit anti-mouse uPA IgG was purified from serum of rabbits immunized with PA purified from conditioned medium of Lewis lung carcinoma cells.
Cell Lines
HEp3 cells (Toolan, 1954) were obtained by collagenase dissociation of HEp3 tumors, serially passaged on CAMs of 10-d-old chick embryos, using previously described techniques (Ossowski and Reich, 1980) . HeLa cells maintained in our laboratory were originally obtained from Dr. J. Nevins (Rockefeller University), and Wish-mUK, a human cell line transfected with mouse uPA cDNA , under the transcrptional control of a human heat shock promoter using a previously described vector (Dreano et al., 1987) , was generously donated by Dr. D. Belin (University of Geneva Medical School, Switzerland).
Methods
Quantitation of Tumor Cells in CAM Mesenchyme. HEp3 cells, prepared by dissociation of serially passaged CAM-HEp3 tumors (Ossowski and Reich, 1980) , were grown in culture for 2-4 d and labeled with 0.2 gCi/ml of 125IUdR for 24-48 h. Specific activity of these cells varied from 0.1 to 0.3 cpm/cell. CAMs of 10-d-old embryos, separated from the egg shell by creation of an artificial air chamber (Ossowski and Reich, 1980) , were inoculated with 4 x 105 cells per CAM, incubated for 8 h at 3"/°C, washed in situ five times with PBS (I mi per wash) and excised. Extreme care was taken not to damage the CAMs during this procedure. The CAMs were incubated for 20 min in 35-mm culture dishes with 2 ml of TD buffer (1 liter of TD buffer contains 16 g NaCI, 0.76 g KCI, 0.2 g Na2HPO4 × 7 1-120 and 6 g Sigma 7-9; Sigma Chemical Co.) and trypsin-EDTA (0.05% trypsin, 1 mM EDTA) or in 2 ml of PBS (1 liter of PBS contains 8 g NaCI, 0.2 g KCI, 0.2 g KH2PO4, 2.16 g Na2HPO4 x 7 H20) with 0.15% collagenase and 2.5 % BSA. At the end of incubation the CAMs were carefully removed from the enzyme solutions, rinsed gently in 2 ml of PBS, and counted in a gamma counter. All the PBS washes were centrifuged at low speed and the supernatants and pellets were als0 counted in the gamma counter. Routinely, >95% of the radioactivity was found in the pellets. To ensure that the incorporated ~25IUdR was not released and reused by the surrounding normal cells, CAMs inoculated with radioactive cells were dissociated with collagenase into single cell suspensions 20 and 40 h after inoculation. The specific radioactivity of the tumor cells, which are very large and easily distinguishable from the chick cells, was determined. After correction for the increase in tumor cell number during these periods the specific radioactivity was found to be unchanged.
Preparation of CAMs.
Intact CAMs were prepared as described (Scher et al., 1976) . Briefly, 2 ml of albumin was removed from 5-d-old embryos, before the development of the CAM. The eggs were incubated on their sides in a stationary incubator. This procedure resulted in the creation of a space between the egg shell and the rest of the egg content and allowed forthe development of the CAM unattached to the egg shell membrane. Wounded CAMs were prepared in 10-d-old embryos by puncturing the egg shell on the long side of the egg and applying negative pressure through an opening in the egg shell over the natural air sac. This procedure, which led to the formation of a new air sac by mechanical separation of the CAM from the egg shell membrane, resulted in severe damage to the CAM. Resealed CAMs were prepared by the above procedure except that wounding was followed by incubation of eggs, before inoculation, for periods varying from 7 to 30 h. Histological examinations were done on sections obtained from tissues fixed in buffered formalin, embedded in paraffin, and stained with hematoxylin and eosin.
Plasminogen Activator Determinations. All methods used have been described previously (Ossowski and Reich, 1980; Strickland and Beers, 1976) . We found that the radioactive fibrin plate method (Stricldand and Beers, 1976) and the assay which used chromogenic substrate for plasmin (Spectrozyme PL; American Diagnostiea Inc.) (Mira-y-Lopez and Ossowski, 1987; Verheijen et al., 1982) , gave comparable results. Both assays detected as little as 0.5-1 mU of uPA.
Detection of uPA Receptors and Determination of Receptor-bound uPA Activity. HeLa, HEp3, and Wish-mUK cells were plated at 2 × 105 in 24-well tissue culture trays and incubated with iodinated high molecular weigh uPA (HMW-uPA) as previously described Stoppelli et al., 1986) . 20-fold excess of unlabeled HMW-uPA (catalytically active or inactivated by incubation with 20 mM DFP for 60 min at 37°C, followed by extensive dialysis) was used to determine the nonspecific binding. Low molecular weight uPA could neither bind to the receptor nor could it compete, even at a 100-fold molar excess, for the binding of HMW-uPA. The stripping of occupied receptors was performed as previously described (Stoppelli et al., 1986) . To determine the functional stability of the receptorbound uPA, HeLa cells were plated at 2 × 10 ~ per well in a 96-well tray and the following day all the cultures were washed twice with PBS-BSA. Half of the cultures were incubated in PBS-BSA with 0.1 gg/ml of HMWuPA and the other half, incubated in PBS-BSA alone, served as controls. At different times, eight wells in each group were washed four times with PBS-BSA. Four wells in each group were incubated for 30 min at 37°C with 50 ~tl of PBS-BSA containing 1 mg/ml of human plasminogen, the other four served as background controls (incubated in PBS-BSA alone). The supernatants of all cultures were aspirated, centrifuged, and their plasmin activity was determined.
Preparation of HeLa Cells with Receptor-bound uPA. Cells (2 × 106/ml) detached with Tris-saline-1 mM EDTA (pH 7.4) were resuspended in Dulbecco's medium with 20 mM Hepes and 1 mg/ml BSA (DB-Hepes-BSA) and incubated for 45 min at 4°C with 0, 0.1, 0.2, or 0.4 gg/rnl of HMW-uPA (HeLa cells) and with 0.2 gg/ml (Wish-mUK and HEp3 cells). After three washes with DB-Hepes-BSA the cells were resuspended in PBS containing 1 mg/ml of human plasminogen, dispensed (I00 lxl) into plastic tubes at 2 x 105 per tube, and incubated for 30 min at 37"C. The supernatants were separated by centrifugation and assayed for plasmin activity by fibrin plate or chromogenic assays. As a control, supernatants of cells that had been incubated without plasminogen were mixed with 1 mg/ml of plasminogen, incubated under identical conditions as the experimental, and assayed for plasmin activity. Only the supernatant from HeLa cells, preincubated with 0.4 Ixg/ml of uPA, had a small but detectable plasmin activity when subsequently mixed with plasminogen; this activity was subtracted from the experimental value.
IdenU'fication of PA 1~pes Produced by Cells. Two methods were used to determine whether the PA produced was of the tPA or the uPA type, and whether it was of mouse or human origin. Lysates and conditioned media of cells were subjected to electrophoresis on SDS-PAGE and simultaneous determinations of molecular weight and activity were performed using zymography (Granelli-Piperno and Reich, 1978) . In addition, cell lysates and conditioned media were preincubated with specific, inhibitory antibodies and the residual PA activity of these mixtures was measured using fibrin plate or chromogenic substrate assays.
Results
Quantitation of Tumor Cells in the CAM Mesenchyme
To quantitate the efficiency of penetration of CAMs by tumor cells, chick embryos were inoculated on CAMs with labeled Two CAMs were inoculated with 2 x 105 ~25IUdR-labeled HEp3 cells (0.23 cpm/cell) and, after 8 h of incubation, the CAMs were washed in situ five times with 1 ml of PBS. Care was taken not to damage the CAMs during washing. The CAMs were excised and incubated at 37°C in 2 ml of 0.05% trypsin and 1 mM EDTA. At indicated times, the CAMs were removed, counted in a gamma counter, and reincubated in fresh enzyme solutions. The results shown are the average of two CAMs and are expressed as percent of total radioactivity recovered in washes, released by trypsin, and found associated with the CAMs. The total recovered radioactivity was 80% of inoculum. tumor cells. At the end of 8 h of incubation the CAMs were subjected to repeated washing with PBS which removed nearly half of the total radioactive tumor cells. Subsequently, the washed CAMs were excised and incubated in trypsin-EDTA solution; an additional 25% of all cells was released in the first 20 min of this treatment, the rest of the radioactive cells (30% of the total number of recovered cells) was completely resistant to further treatment with the enzyme (Fig.  1) , and remained associated with the CAMs even after 1 h of incubation (not shown). CAMs of embryos inoculated with tumor cells and incubated for periods of up to 72 h, contained greater proportions (up to 80%) of cells protected from the action of trypsin. To identify the trypsin-protected compartment by histology, CAMs incubated for 40 h after inoculation with tumor cells were excised and sectioned before and after trypsin-EDTA treatment (Fig. 2) . The comparison of these sections showed that the enzyme treatment primarily released tumor cells attached to the outer surface of the CAM (Fig. 2) , leaving the cells which had penetrated the CAM mesenchyme in place. These cells could only be released by enzymes, such as collagenase, which caused a complete disintegration of the CAM structure (not shown). Similar resuits were seen with CAMs examined 8 h after inoculation but, in this case, the number of tumor cells in the CAM mesenchyme was too small for efficient visualization in histological sections.
Effect of Structural Integrity of CAMs on the Susceptibility to Invasion by Tumor Cells
Different experimental procedures used to prepare CAMs for and Methods, was excised, folded to fit more surface area into a single histological section, and fixed. The photomicrograph shows a section through CAM in which, due to folding, two chorionic epithelia face each other. Note the continuity of the epithelium and the richness of the vasculature immediately adjacent to the epithelium. (B and C) Wounded CAMs were excised from 10-d-old embryos (see Materials and Methods), fixed immediately, and used for preparation of histological sections. Note that this method of CAM preparation resulted in some areas in the disappearance of the entire chorionic epithelium from the surface of the CAM (B), and that extensive bleeding was evident in other areas of the CAM (C). (D and E) Resealed CAMs were prepared by incubating embryos with wounded CAMs for 30 h, followed by excision and fixation of the CAMs. Note that the fibroblasts in the mesenchyme are aligned perpendicularly to the surface, but that on the surface they form an almost continuous multilayered (D) or double-layered (E) sheet. CE, chorionic epithelium; BV, blood vessel; RBC, red blood cells; AE, allantoic epithelium.
tumor cell inoculation yielded CAMs with a variable degree of epithelial injury. We examined the morphology of the CAMs prepared by three methods and compared their sensitivity to tumor cell invasion. We found that in an intact CAM (see Materials and Methods for preparation) the chorionic epithelium, which is known to be composed of one to four layers of cells resting on a basement membrane, remained in its original state ( Fig. 3 A) ; a large number of capillary blood vessels was present in the mesenchyme immediately underlying the epithelium. In contrast, in the wounded CAMs, prepared by a routinely used method of an artificial air sac formation, the chorionic epithelium was completely missing in many areas of the CAM (Fig. 3 B) , and extensive hemorrhage was often observed immediately after wounding ( Intact, wounded, and resealed CAMs were inoculated with radioactive HEp3 cells and, after 20 h of incubation, the number of tumor cells that had laenetrated the mesenchyme was quantitated using the trypsin-EDTA incubation. In the wounded CAMs, 50% and in the CAMs resealed for 7 h 40% of the inoculum was found in the mesenchyme. In contrast, only 23 % of the inoculated tumor cells was found in the mesenchyme of CAMs wounded and resealed for 28 h. Intact CAMs were completely resistant to invasion by HEp3 cells (Fig. 4) . 
Involvement of PAs in CAM Invasion
The role of uPA in CAM invasion was examined by comparing the invasive ability of HEp3 cells expressing high levels of uPA activity to HEp3 cells in which uPA activity was inhibited by anti-uPA IgG (Ossowski and Reich, 1983) , or in which enzyme production was blocked by preincubation with 1.3% DMSO (Ossowski and Belin, 1985; Ossowski, 1988) , a treatment that reduced the HEp3-uPA activity by >90%.
Wounded or resealed CAMs were inoculated with control, anti-uPA IgG-treated or DMSO-treated HEp3 cells, and the number of tumor cells in CAM mesenchyme was determined 20 h later. The inhibition of uPA activity or production only slightly reduced the number of tumor cells found in the mesenchyme of CAMs which were susceptible to invasion, i.e., wounded CAMs and CAMs resealed for 8 h (Table I) . However, in CAMs resealed for 30 h, which, as shown above (Fig. 4) , were more resistant to penetration by tumor cells, the inhibition of tumor cell uPA reduced the cell number found in the CAM mesenchyme by ~75 % (Table I) .
Can Invasiveness Be Enhanced by
Stimulation of tPA Production?
HeLa cells, which endogenously produce only low levels of tPA, were preincubated with epidermal growth factor, a treatment which resulted in a 39-fold increase in the tPA activity released by the cells over a 24-h period (Table II) ; the cellassociated activity rose only 4-fold (Table II) . This enhanced production was maintained for at least 24 h after the removal of the growth factor from the incubation medium (Table II) indicating that, once the production was initiated, it proceeded in the absence of an exogenous stimulus. Both the released and the cell-associated activity were completely inhibited by anti-tPA IgG (not shown). As is evident from Fig.  5 , the ability to produce greatly enhanced levels of tPA did not increase the efficiency of penetration of wounded or resealed CAMs.
Is Binding of uPA to Cell Surface Receptors a Prerequisite for uPA Enhancement of Invasion?
To test whether stimulation of production and release of uPA is sufficient to enhance tumor cell invasiveness, we used a human cell line (Wish) transfected with a mouse uPA-cDNA under the transcriptional control of a human heat shock promoter. Wish-mUK cells were induced to synthesize mouse uPA by 2 h of exposure to 43°C. As seen in Fig. 6 , between 6 and 24 h after the heat shock, PA production in these cells rose from undetectable levels to almost 1,000 mU/106 cells. Most of the PA activity was found in the conditioned medium (Fig. 6) . The mouse origin of the cell associated and the secreted PAs was ascertained by zymography (GranelliPiperno and Reich, 1978) and by inhibition of activity with specific rabbit anti-mouse uPA IgG (not shown). It has been previously established that the binding of uPA to its receptor On day 1, four cultures received 2 ng/ml of EGF and two served as controls; on day 2, all cultures were washed and two of the cultures, preincubated in EGF, were left without the growth factor; on day 3, media and cells were collected and used to determine PA activity. The numbers represent the mean PA in two cultures. Each PA determination was done in duplicate. The difference between assay duplicates was <14% and between duplicate cultures, <22%. The activity of cell-associated and cell-free PA was completely inhibited by preincubation with 200 ~tg/ml of rabbit anti-tPA lgG and not inhibited by 200 ~tg/ml of rabbit anti-uPA lgG. EGF concenlrotion (ng/ml) Figure 5 . The lack of tPA effect on cell invasiveness. HeLa cells treated with 2 ng/ml of EGF exactly as described in the legend to is species restricted (Appella et al., 1987; Huarte et al., 1987) . By using a published procedure (Stoppelli et al., 1986) we examined the binding kinetics of human 'z~I-labeled HMW-uPA to Wish-mUK cells and, from a Scatchard plot, calculated the receptor site number for uPA to be 100,000 per cell. The uPA receptors were found to be unoccupied in both control cells, which do not produce uPA, and in heat shock-induced ceils which produce 1,000 mU per 106 cells Time ofter heot shock (h) Figure 6 . Stimulation of uPA activity in human cells (Wish-mUK) transfected with mouse uPA DNA. Wish-mUK cells were plated in 25-cm 2 flasks at 2.5 x 1@ cells per flask. When semiconfluent, they were filled with medium containing 5 % FBS and heat shocked by submerging in a 43°C water bath for 2 h. 6 h after exposure to heat, and every 24 h thereafter, the medium and cells from two flasks were collected and used to determine PA activity. Medium was replaced in all remaining flasks. The results given are the averages of two flasks and four PA determinations. The values did not differ by >7%. All of the PA activity was shown by zymography (Granelli-Piperno and Reich, 1978) Figure 7 . Invasion of CAM by control and mouse uPA producing Wish-mUK cells. 125IUdR-labeled (0.2 cpm/cell) control and heat-shocked cells, used immediately, 6, and 24 h after the exposure to 43°C, were inoculated onto wounded and resealed CAMs (3 x 105 cells per CAM). After 20 h of incubation the CAMs were excised and tumor cell invasion was quantitated as described in Materials and Methods.
of mouse uPA. This indicated that the endogenously produced uPA did not bind to receptors present on human cells (results not shown).
The invasive ability of these cells (controls and heat shocked, taken immediately after exposure to 43°C or incubated for an additional 6 or 24 h) was examined by inoculation onto wounded and resealed (30 h) CAMs. As shown in Fig. 7 , cells stimulated to produce very high levels of mouse uPA, which is unable to bind to human uPA receptors, were not more invasive than control cells, suggesting that membrane localization of uPA may be crucial for the enhancement of invasion.
To test this possibility more directly, Wish-mUK and HeLa cells were preincubated with uPA in vitro, a treatment that equipped them with surface-bound enzyme. The number of uPA receptors on HeLa cells was calculated from Scatchard analysis to be 37,000; the dissociation constants for uPA on both HeLa and Wish-mUK cells were found to be in the subnanamolar range. In the native state the receptors in both types of cells were unoccupied (not shown); Wish-mUK cells did not produce detectable PA, while the line of HeLa cells used produced tPA exclusively. Incubation of HeLa cells with increasing concentrations (0.1-0.4 ltg/ml) of human HMW-uPA yielded cells with greatly enhanced, surface-bound plasminogen-activating activity (Fig. 8) ; HeLa cells exposed to 0.2 Itg/ml of uPA (a concentration 10 times in excess of the calculated Kd value for uPA binding) were most effective in activation of plasminogen to plasmin (Fig.  8) . More than 50% of the surface-bound enzyme remained active 8 h after it was bound to the receptors (Fig. 9) . bated for 30 min at 37°C with or without 1 mg/ml of human plasminogen. At the end of incubation, the cells were removed by centrifugation and the supernatants were assayed for plasmin activity by a fibrin plate assay (Strickland and Beers, 1976) . The results are the average of two determinations which did not differ by >4%. Incubotion ot 37'C (h) Figure 9 . The stability of plasminogen-activating activity of receptor-bound uPA. HeLa cells were plated at 2 x 104 cells per well in a 96-well tray and incubated overnight in medium with 5 % FBS. The next day the cultures were incubated for 45 min at 4°C, half of the cultures in 0.1 I.tg/ml HMW-uPA in PBS with 1 mg/ml of BSA and the other half in PBS with BSA alone. At the indicated times, eight control wells and eight wells that were preincubated with uPA were washed extensively with PBS/BSA; four wells in each group were incubated for an additional 30 min with 50 I~1 PBS containing 1 mg/ ml of human plasminogen, the other four incubated with PBS/BSA, served as background controls. The supernatants were collected, centrifuged, and their plasmin content was determined on a fibrin plate assay (Strickland and Beers, 1976) . The results shown are the mean of four wells, the bars indicate standard deviation.
To compare the invasiveness of the native HeLa cells to those in which the receptors were saturated with uPA, the cells were inoculated onto wounded CAMs, or CAMs resealed for 30 h. 26% of the inoculated control HeLa cells were found in the mesenchyme of the wounded CAMs; the presence of receptor-bound uPA did not significantly increase this number (Fig. 10 A) . In contrast, only 1.3% of the inoculated control HeLa cells was found in the mesenchyme of the resealed CAMs. Binding of uPA to its receptor by preincubation of HeLa cells with 0.2 lxg/ml of uPA increased their invasive ability eightfold ( Fig. 10 B) ; higher concentration of uPA was slightly less effective (Fig. 10 B) .
Similar results were obtained with Wish-mUK cells prein- cubated with 0.2 ~tg/ml of HMW-uPA; this treatment increased the surface plasminogen-activating activity of these cells from an undetectable level to •40% of the level found in HeLa cells preincubated with a similar concentration of uPA (Fig. 8) . In three separate experiments the average invasion rate of the control cells was 4.2% (+ 1.4) of the inoculum. Binding of uPA increased the efficiency of invasion to 14.7% (+ 3.4) (not shown).
As expected, preincubation of HEp3 cells, in which approximately 90% of the receptors was occupied by endogenously produced uPA (unpublished observations); exogenous enzyme neither increased their plasminogen-activating activity (Fig. 8) nor affected their invasive potential (Fig. 10 C) .
Discussion
Two aspects of the results presented here deserve discussion: the usefulness of the CAM as a model for studying invasion of normal tissues by tumor cells, and the role of proteolysis, initiated by plasminogen activators produced by tumor cells, in this process.
The search for an universally useful model in which to study invasion, and particularly the invasion of connective tissue, has not been entirely satisfactory; in vivo studies of organ invasion are difficult to quantitate (Easty and Easty, 1974; Mareel et al., 1975; Noguchi et al., 1978) and most in vitro models, although simple and rapid, use acellular and avascular membranes that do not mimic the in vivo conditions.
The CAM has been extensively used for serial passage of heterologous tumors (Harris, 1958 (Harris, -1959 Karnofsky et al., 1952; Leighton, 1964) as well as for studying some aspects of invasion (Armstrong et al., 1982; Ossowski, 1988; Scher et al., 1976) . However, the fact that in many studies the state of morphological integrity of the CAMs used in invasion assays was not rigorously determined contributed to a diversity of experimental results (Poste et al., 1979; Poste and Flood, 1979; Scher et al., 1976) .
We found that intentional alteration of structural integrity of CAMs used for tumor cell inoculation had a profound effect on their susceptibility to invasion. Even highly malignant human tumor cells (HEp3), which were invasive and metastatic in the patient (Toolan, 1954) , the chick embryo (Harris, 1958 (Harris, -1959 Ossowski and Reich, 1980) , and the nude mouse were unable to penetrate CAMs in which the epithelium was left intact (Figs. 3 A and  4) . In view of the fact that during the natural course of malignant dissemination the need to breach intact epithelia rarely exists, this may not be surprising.
A completely different outcome was observed in wounded CAMs. The areas of CAMs used for tumor cell inoculation were mostly denuded of epithelium and, as judged by the presence of hemorrhage from the underlying capillaries, this treatment also disrupted the basal laminae (Fig. 3, B and 6"). Although some difference was observed between the different cell lines (HEp3: metastatic [Ossowski and Reich, 1980] , Wish and HeLa: tumorigenic [Dreano et al., 1987; Noguchi et al., 1978] ), all three cell lines showed relatively high efficiency (25-50% of inoculum) of mesenchyme invasion (Figs. 1, 2, 4 , 7, and 10). This very high rate of invasion suggests that, in addition to facilitation of tumor cell entry resuiting from the physical damage to the CAM epithelium, wounding may release compounds such as fibronectin or plasminogen which may stimulate migration or exert chemotactic effects (Lacovara et al., 1984; McCarthy et al., 1986; Morioka et al., 1987; Ossowski et al., 1975; Valinsky et al., 1981) .
The response of the CAM to wounding, which resulted in the formation of a surface layer of fibroblast-like cells and, most likely, extracellular matrix, (resealed CAM) provided a selective model in which highly malignant cells like HEp3 were found to be more invasive than less malignant cells like HeLa and Wish (Figs. 7, 8 , and 10, and unpublished results). It cannot be determined at present, however, whether the increased resistance to invasion of the resealed CAMs is the result of the newly formed physical barrier, the gradual reabsorption of bioactive compounds released during wounding, or the result of the changing compositions of the inflammatory cells and their products, or a combination of the above.
The resealed CAM allowed us to examine, in a quantitative way, whether PA was crucial for efficient invasion of the CAM stroma by tumor cells and, if so, which of the enzyme properties was indispensable for this process. We had previously presented histological evidence indicating that the infiltration of the CAM stroma by single tumor cells requires catalytically active uPA (Ossowski, 1988) , an observation that was confirmed in the resealed CAM model. This model also provided an opportunity for testing whether the mere production of plasminogen activator by tumor cells is sufficient to endow them with invasive properties, or whether specific characteristics, such as the type of enzyme and its localization in the cell, are important determinants.
It became evident from our results that even greatly enhanced (39-fold) tPA activity, achieved by incubation of HeLa cells with EGF, did not increase their invasive potential (Fig. 7) . This lack of effect could not be easily explained by the need of fibrin to fully express tPA activity since, even in the absence of fibrin, plasminogen activation by EGFstimulated cells was nearly equal to that generated by the highly invasive HEp3 cells (not shown). Also, evidence of hemorrhage was noted in CAMs after wounding (Fig. 3 C) , suggesting that fibrin may have been present.
Receptors for tPA, unlike the widely distributed uPA receptors, have been shown to be present on endothelial cells (Hajjar et al., 1987) but not on tumor cells. We found that preincubation of HeLa cells with exogenous tPA did not enhance their PA activity (unpublished data). It appeared, therefore, that the most likely explanation for the lack of effectiveness oftPA in enhancing invasion may be its inability to bind to cell membranes. Additional support for this conclusion was obtained through the use of human Wish-mUK cells, which were stimulated to produce and secrete very high levelsof mouse uPA which remained in the medium because it could not bind to the human uPA receptors. Stimulation of mouse uPA production by these cells did not result in augmentation of their invasive ability. This ineffectiveness was not, most likely, due to the secretion of uPA in a proenzyme form since the highly malignant and invasive HEp3 cells produce exclusively pro-uPA (Wun et al., 1982) .
In vitro conversion of chicken plasminogen to plasmin by human uPA, tPA, and mouse uPA in solution was found to be very inefficient (not shown), suggesting that, most likely, soluble plasmin cannot account for the observed enhancement of tumor cell invasion. Chicken plasmin generation was slightly enhanced when cells (HEp3 and others) that have receptor bound uPA, were plated directly on fibrin (not shown). That surface-bound proteases may create more favorable conditions for localized proteolysis has been suggested previously (Chapman et al., 1984; Plow et al., 1986; Stoppelli et al., 1986) . The results in this paper provide experimental support for this notion: saturation of HeLa cell receptors with exogenous uPA resulted in an eightfold enhancement of their invasiveness. This effect was not seen when tPA production was equally stimulated. A similar result was noted in Wish-mUK cells: secretion of mouse uPA, unable to bind to the human receptors on these cells, did not affect their invasiveness, while a 3.5-fold enhancement of invasiveness was observed when human uPA was bound to their surface receptors.
The reasons for the effectiveness of the cell-bound activity remain to be explored; the enhancing effect of uPA may be due to the generation of proteolysis in critical sites of contact between cells and substratum (Hebert and Baker, 1988; Ptllanen et al., 1988) , or because of increased interaction between the enzyme and the substrate due to higher local enzyme concentration (Plow et al., 1986; Stoppelli et al., 1986) , or, possibly, as suggested (Campbell and Campbell, 1988; Chapman et al., 1984) , because receptor-bound uPA is protected from inhibition by serum and/or cellular PA inhibitors.
